Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine real-world study in pediatric chronic heart failure
ChiCTR2100053569Phase 4Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ivabradine in chronic heart failure (CHF) (2 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoint: heart rate. Started Jul 2021; status: recruiting.
02
Drugs
ivabradine
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR2100053569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053569.